LOS ANGELES CAPITAL MANAGEMENT LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1177206 LOS ANGELES, CA

Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$34,305,979

+$14,662,096 QoQ

Shares Held

203,548

+36.5% QoQ

Ownership

0.200%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#84

of 773 holders

Holding Since

Mar 2020

23 quarters on record

Voting authority Sole 49% Shared 0% None 51%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

LOS ANGELES CAPITAL MANAGEMENT LLC holds $64,712,202 across 30 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (53.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc This page	203,548	$34,305,979
2	VTRS	Viatris Inc	751,406	$11,932,327
3	LQDA	Liquidia Corp	54,603	$4,353,497
4	KNSA	Kiniksa Pharmaceuticals International, plc	50,786	$3,247,764
5	COLL	Collegium Pharmaceutical, Inc	89,443	$3,237,836
6	PAHC	Phibro Animal Health Corp	67,083	$2,106,406
7	IRWD	Ironwood Pharmaceuticals Inc	342,293	$1,441,053
8	AKBA	Akebia Therapeutics, Inc.	531,813	$606,266

All Filings in NBIX

Export CSV

23 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$34,305,979	203,548	+36.5%	Shares	Sole	2026-08-13
2026-03-31	$19,643,883	149,111	-88.5%	Shares	Sole	2026-05-08
2025-12-31	$183,141,958	1,291,278	+7.4%	Shares	Sole	2026-02-11
2025-09-30	$168,842,887	1,202,756	+61.5%	Shares	Sole	2025-10-20
2025-06-30	$93,595,058	744,650	+19454.9%	Shares	Sole	2025-08-07
2025-03-31	$421,164	3,808	-99.3%	Shares	Sole	2025-05-05
2024-12-31	$69,999,930	512,820	+21.9%	Shares	Sole	2025-02-04
2024-09-30	$48,478,584	420,748	+639.6%	Shares	Sole	2024-11-04
2024-06-30	$7,831,357	56,885	-76.8%	Shares	Sole	2024-08-05
2024-03-31	$33,842,947	245,381	-73.3%	Shares	Sole	2024-04-05
2023-12-31	$121,007,198	918,391	+66.0%	Shares	Sole	2024-02-06
2023-09-30	$62,258,062	553,405	+0.5%	Shares	Sole	2023-11-06
2023-06-30	$51,921,391	550,598	-13.3%	Shares	Sole	2023-08-03
2023-03-31	$64,259,010	634,845	-16.9%	Shares	Sole	2023-05-04
2022-12-31	$91,215,372	763,692	-3.6%	Shares	Sole	2023-02-06
2022-09-30	$84,114,708	791,966	+5550.4%	Shares	Sole	2022-11-02
2021-09-30	$1,344,274	14,016	-27.0%	Shares	Sole	2021-11-08
2021-06-30	$1,867,862	19,193	-65.4%	Shares	Sole	2021-08-05
2021-03-31	$5,392,318	55,448	-61.9%	Shares	Sole	2021-05-05
2020-12-31	$13,959,306	145,637	-17.6%	Shares	Sole	2021-03-10
2020-09-30	$16,996,953	176,757	+32.8%	Shares	Sole	2020-11-02
2020-06-30	$16,241,372	133,126	+1144.7%	Shares	Sole	2020-08-05
2020-03-31	$925,652	10,695	—	Shares	Sole	2020-05-04
No filing history on record for this holder in this stock.